Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
52 hedge funds and large institutions have $104M invested in Sinovac Biotech, Ltd in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 1 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 1
111% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 9
37% more capital invested
Capital invested by funds: $75.9M → $104M (+$28.2M)
30% more funds holding
Funds holding: 40 → 52 (+12)
39% less call options, than puts
Call options by funds: $268K | Put options by funds: $438K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.16M |
| 2 |
Jane Street
New York
|
+$1.36M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.3M |
| 4 |
Two Sigma Investments
New York
|
+$1.05M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$778K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$2.84M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$326K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$325K |
| 4 |
Morgan Stanley
New York
|
-$234K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$213K |
SVA Hedge Fund Activity: Q1 2014 in Review
52 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q1 2014, worth a combined $104M — up 37% from $75.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new SVA positions and 1 closed out — a net gain of 12 holders — while 19 added to existing stakes and 9 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $8.16M. The largest seller was Pine River Capital Management, cutting an estimated $2.84M.
- 52 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q1 2014, up from 40 in Q4 2013.
- Funds reported $104M of Sinovac Biotech, Ltd stock for Q1 2014, up 37% quarter-over-quarter.
- 13 funds opened new Sinovac Biotech, Ltd positions in Q1 2014 and 1 closed out, a net change of +12 holders.
- The largest Sinovac Biotech, Ltd buyer in Q1 2014 was Wellington Management Group, an estimated $8.16M added.
- The largest Sinovac Biotech, Ltd seller in Q1 2014 was Pine River Capital Management, an estimated $2.84M sold.
Based on aggregated 13F filings for Q1 2014.